Preventing RSV Infection in Pregnancy
Vaccination Recommendations
- The Centers for Disease Control and Prevention (CDC) recommends RSV vaccination for pregnant persons at 32-36 weeks' gestation during September-January in most of the continental United States 1, 4
- Vaccination should be timed 1-2 months before the anticipated start of RSV season and continue through 2-3 months before the anticipated end of the season 1, 2
- In regions with different RSV seasonality (Alaska, southern Florida, Guam, Hawaii, Puerto Rico, U.S.-affiliated Pacific Islands, and U.S. Virgin Islands), providers should follow local guidance on vaccination timing 1, 4
- RSV vaccine can be administered simultaneously with other recommended vaccines for pregnant persons (Tdap, influenza, COVID-19) at different anatomic sites on the same day 1, 4
Effectiveness and Safety
- Maternal RSV vaccination provides protection to infants during their most vulnerable period, though protection likely wanes after approximately 3 months 4, 5
- At least 14 days are needed after maternal vaccination for development and transplacental transfer of maternal antibodies to protect the infant 4, 5
- No statistically significant differences were observed between vaccine and placebo groups for preterm birth, low birthweight, or neonatal jaundice outcomes 2, 4
- Current recommendations are for a single lifetime dose; no data are available on efficacy or safety of additional doses during subsequent pregnancies 1, 4
Alternative Protection: Nirsevimab for Infants
- For infants whose mothers did not receive RSV vaccine during pregnancy, nirsevimab (a long-acting monoclonal antibody) is recommended for infants aged <8 months who are born during or entering their first RSV season 1, 4
- Either maternal RSV vaccination or infant nirsevimab administration is recommended, but both are not needed for most infants 1, 4
- Nirsevimab is recommended for all infants born at <34 weeks gestation, regardless of maternal vaccination status 4, 5
Additional Preventive Measures
- Keep high-risk infants away from crowds and situations where exposure to infected people cannot be controlled 6, 7
- Restrict participation in group child care during RSV season when feasible 6, 7
- Practice careful hand hygiene 6, 7
- Ensure all eligible infants and their contacts receive influenza vaccine and other age-appropriate immunizations 6, 7
- Eliminate exposure to tobacco smoke 7